全球新冠病毒诊断市场规模、份额、趋势和成长分析报告（2026-2034）

预计 COVID-19 诊断市场将从 2025 年的 565.7 亿美元成长到 2034 年的 3,354.9 亿美元，2026 年至 2034 年的复合年增长率为 21.87%。

疫情期间，随着医疗系统对快速且准确的检测方法的需求日益增长，全球新冠病毒诊断市场迅速扩张。 PCR检测、抗原检测和抗体检测等诊断技术成为监测病毒传播的关键工具。各国政府和医疗机构大力投资大规模检测项目，大幅提升了医院、检查室和检测中心对新冠病毒诊断解决方案的需求。

推动市场发展的主要因素之一是对感染疾病早期可靠检测的需求。快速诊断试剂盒和就地检验提高了诊断速度，使医护人员能够迅速应对疫情爆发。对诊断基础设施和生物技术研究投入的增加也推动了先进检测技术的发展。

随着分子检测平台和多疾病诊断工具的不断改进，新冠病毒诊断市场预计将进一步发展。从此次疫情中汲取的经验教训促使各国政府加强诊断能力，以因应未来的疫情爆发。快速检测和检查室自动化领域的持续创新将支持全球诊断产业的永续发展。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球新冠病毒诊断市场：依产品与服务划分

• 市场分析、洞察与预测
• 装置
• 试剂和试剂盒
• 服务

第五章 全球新冠病毒诊断市场：依样本类型划分

• 市场分析、洞察与预测
• 鼻咽拭子
• 口腔和咽拭子
• 鼻拭子
• 血
• 其他的

第六章 全球新冠病毒诊断市场：依检测类型划分

• 市场分析、洞察与预测
• 分子（PCR）检测
• 抗原检测
• 抗体（血清学）检测
• 其他的

第七章 全球新冠病毒诊断市场：依侦测方法划分

• 市场分析、洞察与预测
• 即时侦测 (PoC)
• 非临床部位（非PoC）

第八章 全球新冠病毒诊断市场：依最终用途划分

• 市场分析、洞察与预测
• 研究所
• 医院
• 诊断中心和诊所
• 其他的

第九章 全球新冠病毒诊断市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十一章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher ScientificInc
  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Abbott Laboratories
  • Hologic Inc
  • PerkinElmerInc
  • BioMerieux SA
  • Quidel Corporation
  • Luminex Corporation
  • Laboratory Corporation Of America Holdings
  • Quest Diagnostics
  • Altona Diagnostics GmbH
  • Veredus Laboratories
  • 1drop Inc
  • ADT Biotech Sdn Bhd

The COVID-19 Diagnostic Market size is expected to reach USD 335.49 Billion in 2034 from USD 56.57 Billion (2025) growing at a CAGR of 21.87% during 2026-2034.

The global COVID-19 diagnostic market expanded rapidly during the pandemic as healthcare systems required fast and accurate testing methods to detect infections. Diagnostic technologies such as PCR tests, antigen tests, and antibody tests became essential tools for monitoring the spread of the virus. Governments and healthcare organizations invested heavily in large-scale testing programs, which significantly boosted the demand for COVID-19 diagnostic solutions across hospitals, laboratories, and testing centers.

One of the major drivers of the market is the need for early and reliable detection of infectious diseases. Rapid diagnostic kits and point-of-care testing have improved the speed of diagnosis, helping healthcare professionals respond quickly to outbreaks. Increased investments in diagnostic infrastructure and biotechnology research have also strengthened the development of advanced testing technologies.

Looking ahead, the COVID-19 diagnostic market is expected to evolve with improved molecular testing platforms and multi-disease diagnostic tools. Lessons learned from the pandemic have encouraged governments to strengthen diagnostic preparedness for future outbreaks. Continued innovation in rapid testing and laboratory automation will likely support sustained growth in the global diagnostics industry.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Service

• Instruments
• Reagents & Kits
• Services

By Sample Type

• Nasopharyngeal (NP) swabs
• Oropharyngeal (OP) swabs
• Nasal swabs
• Blood
• Others

By Test Type

• Molecular (PCR) Testing
• Antigen-based Testing
• Antibody (Serology) Testing
• Others

By Mode

• Point-of-Care (PoC)
• Non-Point-of-Care (Non-PoC)

By End-Use

• Laboratories
• Hospitals
• Diagnostic Centers and Clinics
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific, Inc, F HoffmannLa Roche Ltd, Danaher Corporation, Abbott Laboratories, Hologic Inc, PerkinElmer, Inc, bioMrieux SA, Quidel Corporation, Luminex Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics, Altona Diagnostics GmbH, Veredus Laboratories, 1drop Inc, ADT Biotech Sdn Bhd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Sample Type
• 5.2. Nasopharyngeal (NP) swabs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Oropharyngeal (OP) swabs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Nasal swabs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Test Type
• 6.2. Molecular (PCR) Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Antigen-based Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Antibody (Serology) Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY MODE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Mode
• 7.2. Point-of-Care (PoC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Non-Point-of-Care (Non-PoC) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Diagnostic Centers and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product & Service
  • 9.2.2 By Sample Type
  • 9.2.3 By Test Type
  • 9.2.4 By Mode
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product & Service
  • 9.3.2 By Sample Type
  • 9.3.3 By Test Type
  • 9.3.4 By Mode
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product & Service
  • 9.4.2 By Sample Type
  • 9.4.3 By Test Type
  • 9.4.4 By Mode
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product & Service
  • 9.5.2 By Sample Type
  • 9.5.3 By Test Type
  • 9.5.4 By Mode
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product & Service
  • 9.6.2 By Sample Type
  • 9.6.3 By Test Type
  • 9.6.4 By Mode
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL COVID-19 DIAGNOSTIC INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Thermo Fisher ScientificInc
  • 11.2.2 F. Hoffmann-La Roche Ltd
  • 11.2.3 Danaher Corporation
  • 11.2.4 Abbott Laboratories
  • 11.2.5 Hologic Inc
  • 11.2.6 PerkinElmerInc
  • 11.2.7 BioMerieux SA
  • 11.2.8 Quidel Corporation
  • 11.2.9 Luminex Corporation
  • 11.2.10 Laboratory Corporation Of America Holdings
  • 11.2.11 Quest Diagnostics
  • 11.2.12 Altona Diagnostics GmbH
  • 11.2.13 Veredus Laboratories
  • 11.2.14 1drop Inc
  • 11.2.15 ADT Biotech Sdn Bhd